Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
APILIMOD FOR USE IN THE TREATMENT OF MELANOMA
No-Receipt date
2019-02427 - 26/06/2019
No-Filing date
20190401935 - 26/06/2019
No-Granting date
3100372 - 26/07/2019
No-EPO application date
15795317.5 - 06/11/2015
No-EPO granting date
3215157 - 10/04/2019
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
7/2019 - 06/09/2019
Expiration date
07/11/2035
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US201462077127 P07/11/2014/US
US201562115228 P12/02/2015/US
US201562119540 P23/02/2015/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
G01N 33/574
A61P 35/00
A61K 45/06
A61K 31/5377
A61K 31/437
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1086939
AL THERAPEUTICS, INC.
530 OLD WHITFIELD STREET
GUILFORD
CT 06437
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
2596013
BEEHARRY, NEIL
2596014
GAYLE, SOPHIA
2596015
LANDRETTE, SEAN
2596016
BECKETT, PAUL
2596017
CONRAD, CHRIS
2596018
XU, TIAN
2596019
ROTHBERG, JONATHAN M.
2596020
LICHENSTEIN, HENRI
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
6/9/2023 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 05/2023 Αρ. Πρωτ. ΓΔ 1624 / 09.06.23
Payments history
7 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).